309 related articles for article (PubMed ID: 20440215)
1. Combined intravitreal bevacizumab and trabeculectomy with mitomycin C versus trabeculectomy with mitomycin C alone for neovascular glaucoma.
Takihara Y; Inatani M; Kawaji T; Fukushima M; Iwao K; Iwao M; Tanihara H
J Glaucoma; 2011 Mar; 20(3):196-201. PubMed ID: 20440215
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of preoperative intravitreal bevacizumab on trabeculectomy outcomes in neovascular glaucoma.
Saito Y; Higashide T; Takeda H; Ohkubo S; Sugiyama K
Acta Ophthalmol; 2010 Feb; 88(1):96-102. PubMed ID: 19775309
[TBL] [Abstract][Full Text] [Related]
3. Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C.
Alkawas AA; Shahien EA; Hussein AM
J Glaucoma; 2010 Dec; 19(9):622-6. PubMed ID: 20179624
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.
Wakabayashi T; Oshima Y; Sakaguchi H; Ikuno Y; Miki A; Gomi F; Otori Y; Kamei M; Kusaka S; Tano Y
Ophthalmology; 2008 Sep; 115(9):1571-80, 1580.e1-3. PubMed ID: 18440643
[TBL] [Abstract][Full Text] [Related]
5. Surgical outcomes of intravitreal bevacizumab and guarded filtration surgery in neovascular glaucoma.
Fakhraie G; Katz LJ; Prasad A; Eslami Y; Sabour S; Zarei R; Moghimi S
J Glaucoma; 2010 Mar; 19(3):212-8. PubMed ID: 19593201
[TBL] [Abstract][Full Text] [Related]
6. Surgical results of Ahmed valve implantation with intraoperative bevacizumab injection in patients with neovascular glaucoma.
Ma KT; Yang JY; Kim JH; Kim NR; Hong S; Lee ES; Seong GJ; Kim CY
J Glaucoma; 2012; 21(5):331-6. PubMed ID: 21673594
[TBL] [Abstract][Full Text] [Related]
7. Long-term Outcomes After Preoperative Intravitreal Injection of Bevacizumab Before Trabeculectomy for Neovascular Glaucoma.
Kobayashi S; Inoue M; Yamane S; Sakamaki K; Arakawa A; Kadonosono K
J Glaucoma; 2016 Mar; 25(3):281-4. PubMed ID: 25580888
[TBL] [Abstract][Full Text] [Related]
8. Surgical outcome of intravitreal bevacizumab and filtration surgery in neovascular glaucoma.
Kitnarong N; Chindasub P; Metheetrairut A
Adv Ther; 2008 May; 25(5):438-43. PubMed ID: 18425438
[TBL] [Abstract][Full Text] [Related]
9. Trabeculectomy with mitomycin C for neovascular glaucoma: prognostic factors for surgical failure.
Takihara Y; Inatani M; Fukushima M; Iwao K; Iwao M; Tanihara H
Am J Ophthalmol; 2009 May; 147(5):912-8, 918.e1. PubMed ID: 19195639
[TBL] [Abstract][Full Text] [Related]
10. Hyphema is a risk factor for failure of trabeculectomy in neovascular glaucoma: a retrospective analysis.
Nakatake S; Yoshida S; Nakao S; Arita R; Yasuda M; Kita T; Enaida H; Ohshima Y; Ishibashi T
BMC Ophthalmol; 2014 Apr; 14():55. PubMed ID: 24766841
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of treatment of neovascular glaucoma with intravitreal bevacizumab.
Moraczewski AL; Lee RK; Palmberg PF; Rosenfeld PJ; Feuer WJ
Br J Ophthalmol; 2009 May; 93(5):589-93. PubMed ID: 19074917
[TBL] [Abstract][Full Text] [Related]
12. Effect of intravitreal bevacizumab injection before Ahmed glaucoma valve implantation in neovascular glaucoma.
Sevim MS; Buttanri IB; Kugu S; Serin D; Sevim S
Ophthalmologica; 2013; 229(2):94-100. PubMed ID: 23364308
[TBL] [Abstract][Full Text] [Related]
13. Intravitreal bevacizumab for neovascular glaucoma: a randomized controlled trial.
Yazdani S; Hendi K; Pakravan M; Mahdavi M; Yaseri M
J Glaucoma; 2009; 18(8):632-7. PubMed ID: 19826393
[TBL] [Abstract][Full Text] [Related]
14. Intravitreal bevacizumab and augmented trabeculectomy for neovascular glaucoma in young diabetic patients.
Cornish KS; Ramamurthi S; Saidkasimova S; Ramaesh K
Eye (Lond); 2009 Apr; 23(4):979-81. PubMed ID: 18451875
[TBL] [Abstract][Full Text] [Related]
15. Adjunctive with versus without intravitreal bevacizumab injection before Ahmed glaucoma valve implantation in the treatment of neovascular glaucoma.
Zhou MW; Wang W; Huang WB; Chen SD; Li XY; Gao XB; Zhang XL
Chin Med J (Engl); 2013; 126(8):1412-7. PubMed ID: 23595369
[TBL] [Abstract][Full Text] [Related]
16. Long-term results of Ahmed glaucoma valve in association with intravitreal bevacizumab in neovascular glaucoma.
Sahyoun M; Azar G; Khoueir Z; Antoun J; Kourie H; Nehme J; Jalkh A
J Glaucoma; 2015; 24(5):383-8. PubMed ID: 25719230
[TBL] [Abstract][Full Text] [Related]
17. Intraocular pressure following combined routes of bevacizumab-augmented trabeculectomy for refractory neovascular glaucoma.
Chatterjee S; Rao A
Semin Ophthalmol; 2013 Mar; 28(2):72-4. PubMed ID: 23448559
[TBL] [Abstract][Full Text] [Related]
18. Subconjunctival bevacizumab versus mitomycin C adjunctive to trabeculectomy.
Nilforushan N; Yadgari M; Kish SK; Nassiri N
Am J Ophthalmol; 2012 Feb; 153(2):352-357.e1. PubMed ID: 21982106
[TBL] [Abstract][Full Text] [Related]
19. Adjunctive intravitreal bevacizumab-combined trabeculectomy versus trabeculectomy alone in the treatment of neovascular glaucoma.
Chen CH; Lai IC; Wu PC; Chen YJ; Chen YH; Lee JJ; Liu YC; Kuo HK
J Ocul Pharmacol Ther; 2010 Feb; 26(1):111-8. PubMed ID: 20148654
[TBL] [Abstract][Full Text] [Related]
20. Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab.
Saito Y; Higashide T; Takeda H; Murotani E; Ohkubo S; Sugiyama K
Am J Ophthalmol; 2010 Jun; 149(6):964-972.e1. PubMed ID: 20381786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]